Notice on Convening the 2025 Annual General Meeting
Filed with SSE · · 9 pages · Chinese
North China Pharmaceutical Company Ltd. on 6ix
Earlier from North China Pharmaceutical
- Announcement on Renewing Engagement of Accounting Firm
- Announcement on Receipt of Government Land Acquisition and Sale Proceeds Return Payments
- Announcement on Obtaining the Drug Registration Certificate by Subsidiary
- Announcement on Providing Guarantee for Subsidiary
- Announcement on Wholly-owned Subsidiary's Passing GMP Compliance Inspection for Drugs
Later from North China Pharmaceutical
- Announcement on Release of Pledge and Pledge of Some Shares of Shareholders
- Announcement on Convening Performance Briefing for 2025 and Q1 2026
- Announcement on Election of Employee Director
- Announcement on Implementation of Dividend Distribution for 2025
- Announcement on Obtaining Drug Registration Certificate
Follow North China Pharmaceutical into a list and get an email when it puts out news.
Follow North China Pharmaceutical